Patterns of IgE sensitization in house dust mite-allergic patients: Implications for allergen immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 2, 2016, Pages 220-229

  Batard, T ^a   Baron Bodo, V ^a   Martelet, A ^a   Le Mignon, M ^a   Lemoine, P ^a   Jain, K ^a   Mariano, S ^a   Horiot, S ^a   Chabre, H ^a   Harwanegg, C ^b   Marquette, C A ^c   Corgier, B P ^c   Soh, W T ^d   Satitsuksanoa, P ^d   Jacquet, A ^d   Chew, F T ^e   Nony, E ^a   Moingeon, P ^a  

^a Stallergenes SA   (France)

^b Thermo Fisher Scientific   (United States)

^c AXO Science SAS   (France)

^d CHULALONGKORN UNIVERSITY   (Thailand)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

allergen immunotherapy; Dermatophagoides; house dust mite; IgE sensitization

Indexed keywords

DERMATOPHAGOIDES FARINAE EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG; ALLERGEN;

ADOLESCENT; ADULT; AMERICAN; ARTICLE; CANADIAN; CHILD; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; EUROPEAN; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOREACTIVITY; IMMUNOTHERAPY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; SENSITIZATION; SEROEPIDEMIOLOGY; TREATMENT OUTCOME; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; DESENSITIZATION; EUROPE; FEMALE; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PRESCHOOL CHILD; PYROGLYPHIDAE; YOUNG ADULT;

ADOLESCENT; ADULT; ALLERGENS; ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, DERMATOPHAGOIDES; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; EUROPE; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOGLOBULIN E; MALE; PYROGLYPHIDAE; YOUNG ADULT;

EID: 84955308454     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12796     Document Type: Article

References (39)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl 86): 8-160.
2. Thomas WR,. Geography of house dust mite allergens. Asian Pac J Allergy Immunol 2010; 28: 211-224.
3. Moingeon P,. Progress in the development of specific immunotherapies for house dust mite allergies. Expert Rev Vaccines 2014; 13: 1463-1473.
4. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, et al., Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy 2009; 64 (Suppl 91): 1-59.
5. Walgraffe D, Matteotti C, El Bakkoury M, Garcia L, Marchand C, Bullens D, et al., A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines. J Allergy Clin Immunol 2009; 123: 1150-1156.
6. Bordas-Le Floch V, Bussieres L, Airouche S, Lautrette A, Bouley J, Berjont N, et al., Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy. Int Arch Allergy Immunol 2012; 158: 157-167.
7. Marth K, Focke-Tejkl M, Lupinek C, Valenta R, Niederberger V,. Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy. Curr Treat Options Allergy 2014; 1: 91-106.
8. Bouchaud G, Braza F, Chesne J, Lair D, Chen KW, Rolland-Debord C, et al., Prevention of allergic asthma through Der p 2 peptide vaccination. J Allergy Clin Immunol 2015; 136: 197-200.
9. Calamita Z, Saconato H, Pela AB, Atallah AN,. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006; 61: 1162-1172.
10. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, et al., Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008; 133: 599-609.
11. Compalati E, Passalacqua G, Bonini M, Canonica GW,. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy 2009; 64: 1570-1579.
12. Abramson MJ, Puy RM, Weiner JM,. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010; CD001186.
13. Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, et al., Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA 2013; 309: 1278-1288.
14. Calderon MA, Casale TB, Nelson HS, Demoly P,. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol 2013; 132: 1322-1336.
15. Calderon MA, Linneberg A, Kleine-Tebbe J, De Blay F, Fernandez H, de Rojas D, et al., Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol 2015; 136: 38-48.
16. Fernandez-Caldas E,. Towards a more complete standardization of mite allergen extracts. Int Arch Allergy Immunol 2013; 160: 1-3.
17. Batard T, Hrabina A, Bi XZ, Chabre H, Lemoine P, Couret MN, et al., Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol 2006; 140: 295-305.
18. Moingeon P,. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract 2013; 1: 228-241.
19. Akdis M, Akdis CA,. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol 2014; 133: 621-631.
20. Bergmann KC, Demoly P, Worm M, Fokkens WJ, Carrillo T, Tabar AI, et al., Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol 2014; 133: 1608-1614.
21. Harwanegg C, Hutter S, Hiller R,. Allergen microarrays for the diagnosis of specific IgE against components of cow's milk and hen's egg in a multiplex biochip-based immunoassay. Meth Mol Biol 2007; 385: 145-157.
22. Mandon CA, Berthuy OI, Corgier BP, Le Goff GC, Faure P, Marche PN, et al., Polymer adhesive surface as flexible generic platform for multiplexed assays biochip production. Biosens Bioelectron 2013; 39: 37-43.
23. Batard T, Nony E, Chabre H, Hrabina M, Bouley J, Lemignon M, et al., Molecular and functional characterization of natural allergen extracts. Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess 2013; 97: 54-56.
24. Weber E, Hunter S, Stedman K, Dreitz S, Olivry T, Hillier A, et al., Identification, characterization, and cloning of a complementary DNA encoding a 60-kd house dust mite allergen (Der f 18) for human beings and dogs. J Allergy Clin Immunol 2003; 112: 79-86.
25. Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, et al., Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008; 38: 959-965.
26. Thomas WR, Hales BJ, Smith WA,. House dust mite allergens in asthma and allergy. Trends Mol Med 2010; 16: 321-328.
27. Kidon MI, Chiang WC, Liew WK, Ong TC, Tiong YS, Wong KN, et al., Mite component-specific IgE repertoire and phenotypes of allergic disease in childhood: the tropical perspective. Ped Allergy Immunology 2011; 22: 202-210.
28. Barber D, Arias J, Boquete M, Cardona V, Carrillo T, Gala G, et al., Analysis of mite allergic patients in a diverse territory by improved diagnostic tools. Clin Exp Allergy 2012; 42: 1129-1138.
29. Resch Y, Michel S, Kabesch M, Lupinek C, Valenta R, Vrtala S,. Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children. J Allergy Clin Immunol 2015; 136: 1083-1091.
30. Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, et al., Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 2013; 190: 3059-3067.
31. Minami T, Fukutomi Y, Lidholm J, Yasueda H, Saito A, Sekiya K, et al., IgE Abs to Der p 1 and Der p 2 as diagnostic markers of house dust mite allergy as defined by a bronchoprovocation test. Allergology Int 2015; 64: 90-95.
32. Hales BJ, Thomas WR,. T-cell sensitization to epitopes from the house dust mites Dermatophagoides pteronyssinus and Euroglyphus maynei. Clin Exp Allergy 1997; 27: 868-875.
33. Park JW, Kim KS, Jin HS, Kim CW, Kang DB, Choi SY, et al., Der p 2 isoallergens have different allergenicity, and quantification with 2-site ELISA using monoclonal antibodies is influenced by the isoallergens. Clin Exp Allergy 2002; 32: 1042-1047.
34. Hinz D, Oseroff C, Pham J, Sidney J, Peters B, Sette A,. Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens. Clin Exp Allergy 2015; 45: 1601-1612.
35. Tourdot S, Airouche S, Berjont N, Da Silveira A, Mascarell L, Jacquet A, et al., Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation. Clin Exp Allergy 2011; 41: 1784-1792.
36. Chan TF, Ji KM, Yim AK, Liu XY, Zhou JW, Li RQ, et al., The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens. J Allergy Clin Immunol 2015; 135: 539-548.
37. Tovey ER, Chapman MD, Platts-Mills TA,. Mite faeces are a major source of house dust allergens. Nature 1981; 289: 592-593.
38. Park GM, Lee SM, Lee IY, Ree HI, Kim KS, Hong CS, et al., Localization of a major allergen, Der p 2, in the gut and faecal pellets of Dermatophagoides pteronyssinus. Clin Exp Allergy 2000; 30: 1293-1297.
39. Baron-Bodo V, Batard T, Nguyen H, Frereux M, Horiot S, Harwanegg C, et al., Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy. Clin Exp Allergy 2012; 42: 1510-1518.